Efficacy and safety of systematic corticosteroids among severe COVID-19 patients: a systematic review and meta-analysis of randomized controlled trials

The benefits and harms of corticosteroids for patients with severe coronavirus disease 2019 (COVID-19) remain unclear. We systematically searched PubMed, Embase, and Cochrane Central Register of Controlled Trials from December 31, 2019 to October 1, 2020 to identify randomized controlled trials (RCT...

Descripción completa

Detalles Bibliográficos
Autores principales: Ma, Shaolei, Xu, Changsheng, Liu, Shijiang, Sun, Xiaodi, Li, Renqi, Mao, Mingjie, Feng, Shanwu, Wang, Xian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897363/
https://www.ncbi.nlm.nih.gov/pubmed/33612824
http://dx.doi.org/10.1038/s41392-021-00521-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7897363/
https://www.ncbi.nlm.nih.gov/pubmed/33612824
http://dx.doi.org/10.1038/s41392-021-00521-7

Ejemplares similares